2012
DOI: 10.3727/096368912x636993
|View full text |Cite
|
Sign up to set email alerts
|

An Ectopic Stromal Implant Model for Hematopoietic Reconstitution and in Vivo Evaluation of Bone Marrow Niches

Abstract: In adults, hematopoiesis takes places in the bone marrow, where specialized niches containing mesenchymal nonhematopoietic cells (stroma) harbor the hematopoietic stem cell (HSC). These niches are responsible and essential for the maintenance of HSCs. Attempts to expand HSCs fail to keep the general properties of stem cells, which depend on several niche components difficult to reproduce in in vitro culture systems. Here, we describe a methodology for in vivo study of hematopoietic stroma. We use stroma-loade… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 58 publications
0
3
0
Order By: Relevance
“…Although Cx43-deficient (Cx43 −/− ) mice die shortly after birth due to heart malformations [ 86 ], precluding postnatal hematopoietic studies, embryonic Cx43 −/− mice exhibit reduced fetal liver HSC and progenitor cells. Cx43 deficiency in stromal cells, specifically, results in a reduction of functional HSC and progenitor cells in the fetal liver and impairs the growth and differentiation of bone marrow HSC, suggesting that Cx43 acts as critical regulator of hematopoiesis [ 87 , 88 ]. Furthermore, Cx43 was shown to be critical for injury-induced hematopoietic regeneration in adults [ 89 ].…”
Section: Cx43 In Stem Cell Nichesmentioning
confidence: 99%
“…Although Cx43-deficient (Cx43 −/− ) mice die shortly after birth due to heart malformations [ 86 ], precluding postnatal hematopoietic studies, embryonic Cx43 −/− mice exhibit reduced fetal liver HSC and progenitor cells. Cx43 deficiency in stromal cells, specifically, results in a reduction of functional HSC and progenitor cells in the fetal liver and impairs the growth and differentiation of bone marrow HSC, suggesting that Cx43 acts as critical regulator of hematopoiesis [ 87 , 88 ]. Furthermore, Cx43 was shown to be critical for injury-induced hematopoietic regeneration in adults [ 89 ].…”
Section: Cx43 In Stem Cell Nichesmentioning
confidence: 99%
“…Cells were cultured in 10 % fetal calf serum (Cultilab, São Paulo, Brazil) supplemented RPMI 1640 medium (Mediatech, Virginia, USA) at 37 °C in a 5 % CO 2 atmosphere. Alternatively, these cells were cultured in three-dimensional cell culture system using macroporous cellulose microcarriers (Cytopore™, Asaki Kasei Medical Co., GE Healthcare, Japan) as described previously [ 63 ] with some modifications. Briefly, 100 μL of phosphate-buffered saline (PBS)-hydrated macroporous cellulose microcarriers were colonized with cells in a volume of the 2x10 5 cells under nitrocellulose membrane from Transwell™ inserts (Costar, Corning Incorporated, USA) and cultured for 4 days with complete medium at 37 °C in a 5 % CO 2 atmosphere.…”
Section: Methodsmentioning
confidence: 99%
“…For stem cell-targeted rdACT, in vitro and in vivo models that enable the selective evaluation of stem cell-based tumor cell renewal are valuable tools. Such models are available for normal [98] and leukemic [99] hematopoiesis in vitro and in vivo [100,101], and for some models of xenografted tumors [93,100,102].…”
Section: Targeting the Most Relevant Cell Populationmentioning
confidence: 99%